Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03786094
Title Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Polyphor Ltd.
Indications

breast cancer

Therapies

Eribulin

Eribulin + POL6326

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.